Absci vs iSpecimen
ABSI and ISPC side by side, both in engineering, accounting, research, management, and related services. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How ABSI and ISPC compare
Absci is the larger company, worth 972 times as much as iSpecimen ($1.7B against $1.8M).
Absci grew revenue faster over the last twelve months (−47.2% versus −92.1% for iSpecimen).
iSpecimen keeps more of each dollar of sales as profit, with a net margin of −2449% compared with −8451% at Absci.
iSpecimen scores higher on the StockData Score (7 against 5 for Absci), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | ABSI | ISPC |
|---|---|---|
| Size and price | ||
| Market cap | $1.7B | $1.8M |
| Share price | $10.12 | $0.709 |
| Change, 1 year | 205% | −97.2% |
| Change, 5 years | −8.4% | −100.0% |
| Beta (5Y) | 2.22 | 0.61 |
| Employees | 140 | 53 |
| StockData Score | ||
| Total score | 5 | 7 (better) |
| Valuation score | 0 | 3 (better) |
| Growth score | 0 | 0 |
| Performance score | 0 | 0 |
| Health score | 5 (better) | 4 |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/S | 1168× | 3.8× (better) |
| P/B | 7.9× | 1.0× (better) |
| FCF yield | −6.5% | – |
| Fair value | – | $0.985 |
| Margin of safety | – | 28.0% |
| Growth | ||
| Revenue growth (TTM) | −47.2% (better) | −92.1% |
| Revenue growth, 5Y average | −10.1% (better) | −25.1% |
| Profitability | ||
| Gross margin | – | −98.0% |
| Operating margin | −8812% | −2020% (better) |
| Net margin | −8451% | −2449% (better) |
| FCF margin | −7563% | – |
| Return on equity | −58.6% (better) | −968% |
| Return on invested capital | −242% | – |
| Financial health | ||
| Debt / equity | 0.00 | 0.00 |
| Interest coverage | −2569.4× | – |
| Current ratio | 9.64 (better) | 0.82 |
| Altman Z-score | 44.67 (better) | −20.40 |
| Piotroski F-score | 3 | 3 |
| Dividends and buybacks | ||
| Buyback yield | −6.3% | – |
| Shareholder yield | −6.3% | 0.00% (better) |
| Ownership | ||
| Held by institutions | 88.3% | 2.3% |
| Held by insiders | 15.5% | 0.00% |
| Insider net buying, 12 months | $801K | – |
| Short interest, % of float | 24.7% | 12.1% |
Go deeper
- ABSI stock overview
- ABSI income statement
- ABSI valuation and score
- ISPC stock overview
- ISPC income statement
- ISPC valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.